TRIM44 and Cerebral ischemia: Consequently, MC7 stands out as a promising lead compound, pending further mechanistic validation prior to its progression into in vivo studies of cerebral ischemia, where its capacity to reduce infarct volume and preserve neurological function will be further assessed.